scholarly article | Q13442814 |
P2093 | author name string | Russell T Turner | |
Li-Na Wei | |||
Urszula T Iwaniec | |||
Bart L Clarke | |||
Yi-Wei Lin | |||
Anne Gingery | |||
Bomi Lee | |||
P2860 | cites work | A comprehensive review on metabolic syndrome | Q21284500 |
Modulation of testicular receptor 4 activity by mitogen-activated protein kinase-mediated phosphorylation | Q24298816 | ||
RANK is essential for osteoclast and lymph node development | Q24598872 | ||
Influence of body weight on bone mass, architecture and turnover | Q26746262 | ||
Bone resorption by osteoclasts | Q28145169 | ||
An Oct4-centered protein interaction network in embryonic stem cells | Q28278599 | ||
Syk, c-Src, the alphavbeta3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption | Q28592760 | ||
Osteoclast differentiation and activation | Q29547556 | ||
Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts | Q29618116 | ||
The metabolic syndrome | Q33569142 | ||
Cloning and characterization of osteoclast precursors from the RAW264.7 cell line | Q33906787 | ||
Therapeutic approaches to bone diseases | Q34021178 | ||
Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. | Q34319046 | ||
Reducing RIP140 expression in macrophage alters ATM infiltration, facilitates white adipose tissue browning, and prevents high-fat diet-induced insulin resistance | Q34545557 | ||
Absence of Dap12 and the αvβ3 integrin causes severe osteopetrosis | Q34825981 | ||
Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat | Q35006662 | ||
Osteoclast-derived activity in the coupling of bone formation to resorption. | Q36032429 | ||
Reduced osteoblast activity in the mice lacking TR4 nuclear receptor leads to osteoporosis | Q36249254 | ||
Paradoxical effects of partial leptin deficiency on bone in growing female mice | Q36296663 | ||
Osteoclast TGF-β Receptor Signaling Induces Wnt1 Secretion and Couples Bone Resorption to Bone Formation. | Q36593362 | ||
Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis | Q36636165 | ||
New insights into osteoporosis: the bone-fat connection | Q36791099 | ||
Relationship of weight, height, and body mass index with fracture risk at different sites in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW). | Q36931661 | ||
DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes. | Q37021520 | ||
Growth retardation and abnormal maternal behavior in mice lacking testicular orphan nuclear receptor 4. | Q37589827 | ||
Energy Excess, Glucose Utilization, and Skeletal Remodeling: New Insights | Q38533278 | ||
Receptor-Interacting Protein 140 Orchestrates the Dynamics of Macrophage M1/M2 Polarization | Q38847682 | ||
Combined high-fat-resveratrol diet and RIP140 knockout mice reveal a novel relationship between elevated bone mitochondrial content and compromised bone microarchitecture, bone mineral mass, and bone strength in the tibia | Q39896236 | ||
TGF-beta coordinately activates TAK1/MEK/AKT/NFkB and SMAD pathways to promote osteoclast survival. | Q39967368 | ||
Association of sustained ERK activity with integrin beta3 induction during receptor activator of nuclear factor kappaB ligand (RANKL)-directed osteoclast differentiation | Q40633472 | ||
The use of human CD68 transcriptional regulatory sequences to direct high-level expression of class A scavenger receptor in macrophages in vitro and in vivo | Q40792529 | ||
Clinical review 83: Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis | Q41150682 | ||
NF-κB-mediated degradation of the coactivator RIP140 regulates inflammatory responses and contributes to endotoxin tolerance | Q42574729 | ||
Multilocus analysis of estrogen-related genes in Spanish postmenopausal women suggests an interactive role of ESR1, ESR2 and NRIP1 genes in the pathogenesis of osteoporosis | Q43532541 | ||
Histological analysis of bone | Q46277868 | ||
Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis | Q47761859 | ||
Involvement of receptor-interacting protein 140 in estrogen-mediated osteoclasts differentiation, apoptosis, and bone resorption. | Q53136784 | ||
Estrogen-related genes and postmenopausal osteoporosis risk. | Q53663375 | ||
The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene | Q59092154 | ||
The coupling of bone formation to bone resorption: a critical analysis of the concept and of its relevance to the pathogenesis of osteoporosis | Q70459032 | ||
Bone loss and bone turnover in diabetes | Q72332597 | ||
Negative feedback control of the retinoid-retinoic acid/retinoid X receptor pathway by the human TR4 orphan receptor, a member of the steroid receptor superfamily | Q74567346 | ||
Tissue-specific and cell type-specific RNA interference in vivo | Q80093210 | ||
Screening and functional microarray analysis of differentially expressed genes related to osteoporosis | Q87906919 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | e90517 | |
P577 | publication date | 2017-04-06 | |
P1433 | published in | JCI insight | Q27727187 |
P1476 | title | RIP140 in monocytes/macrophages regulates osteoclast differentiation and bone homeostasis | |
P478 | volume | 2 |
Q92266229 | A new regulatory mechanism for Raf kinase activation, retinoic acid-bound Crabp1 |
Q48159039 | Implication of molecular vascular smooth muscle cell heterogeneity among arterial beds in arterial calcification. |
Q94550612 | QKI deficiency leads to osteoporosis by promoting RANKL-induced osteoclastogenesis and disrupting bone metabolism |
Q92701745 | Regulation of Hedgehog signaling Offers A Novel Perspective for Bone Homeostasis Disorder Treatment |